CHRNA5 rs147144681: What Your Genotype Means
The rs147144681 variant is a genetic marker located within the CHRNA5 gene, which plays a role in how the brain responds to nicotine. Research has identified this specific SNP as being associated with nicotine dependence in individuals of European ancestry.
What each genotype means
Associated with nicotine dependence
This genotype is associated with an increased risk for nicotine dependence and may influence smoking behaviors. Research indicates that variants in this region of the CHRNA5 gene are linked to how the brain responds to nicotine, though these associations are complex and influenced by other genetic and environmental factors. Please discuss any concerns regarding smoking cessation or substance use with your healthcare provider.
The frequency of this genotype varies significantly across different ancestral populations.
Intermediate nicotine dependence risk
Carrying one copy of this variant may result in an intermediate influence on nicotine dependence risk compared to other genotypes. The CHRNA5 gene plays a role in nicotinic receptor signaling, and this specific variant is recognized as a lead marker in studies of smoking-related traits. As this association is statistical in nature, please consult with a clinician or pharmacist for personalized health guidance.
This genotype is observed at varying frequencies depending on the specific ancestral background of the individual.
Typical nicotine response profile
This genotype represents the more common or baseline state for this specific marker in many populations. While this variant is a known lead SNP for nicotine dependence research, individuals with this genotype do not carry the specific risk-associated allele identified in recent genome-wide association studies. Always consult with a medical professional regarding your personal health history and smoking-related concerns.
This is the most common genotype in many populations, though prevalence is variable across global ancestries.
Understanding the rs147144681 Variant
The rs147144681 variant is a single-nucleotide polymorphism (SNP) located on chromosome 15 within the CHRNA5 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant has been identified through genome-wide association studies (GWAS) as a lead SNP, meaning it is a primary marker used by researchers to track a specific genetic signal within a population. Because it sits within a region of the genome known for its involvement in substance use, scientists study it to better understand the biological underpinnings of nicotine dependence. It is important to note that while this variant is a statistical marker, it does not act in isolation; it is part of a complex genetic landscape that influences how individuals interact with nicotine and other substances.
The Role of the CHRNA5 Gene
The CHRNA5 gene provides instructions for creating the alpha-5 subunit of neuronal nicotinic acetylcholine receptors. These receptors are proteins found on the surface of nerve cells that act as channels, allowing ions to flow into the cell when activated by neurotransmitters like acetylcholine or external substances like nicotine. By co-assembling with other subunits, the alpha-5 protein helps form receptors that are highly permeable to calcium, which is essential for excitatory signaling in the brain. Because these receptors are located in areas of the brain involved in reward and reinforcement, variations in the CHRNA5 gene can influence how sensitive a person's brain is to nicotine. This sensitivity is thought to contribute to the biological processes that underlie nicotine addiction and the difficulty some individuals may face when attempting to quit smoking.
Research and Evidence Strength
Current research, including large-scale genome-wide association studies, has established a significant statistical link between rs147144681 and nicotine dependence, particularly in populations of European ancestry. For example, studies have reported p-values indicating a strong association, suggesting that this variant is a reliable marker for identifying genetic susceptibility to nicotine-related traits. However, the evidence strength is considered limited in terms of clinical application. While the association is statistically robust, nicotine dependence is a multifactorial condition influenced by a combination of genetic, environmental, and behavioral factors. The presence of this variant does not guarantee that an individual will develop dependence, nor does its absence provide immunity. Researchers continue to investigate how this variant interacts with other genes in the CHRNA5/A3/B4 cluster to refine our understanding of addiction liability.
Population Frequency and Variability
The frequency of the rs147144681 variant is known to be variable across different ancestral populations. Genetic studies often observe that certain alleles are more common in specific geographic or ethnic groups, which can influence the strength of the observed association in those populations. Because most large-scale studies on this variant have focused on individuals of European ancestry, there is less data available regarding its impact and frequency in other groups. This variability highlights the importance of considering ancestry when interpreting genetic data. As more diverse genomic datasets become available, researchers hope to gain a clearer picture of how this variant is distributed globally and whether its association with nicotine dependence remains consistent across different human populations.
Interpreting Your Genetic Information
It is essential to understand that genetic variants like rs147144681 are tools for scientific research rather than diagnostic instruments. Having a specific genotype at this location does not provide a medical diagnosis or a definitive prediction of future health outcomes. If you are concerned about nicotine use or are seeking support for smoking cessation, the most effective approach is to consult with a healthcare professional or a qualified pharmacist. They can provide personalized guidance based on your medical history and current health status. You should never use genetic information to make decisions about medication or treatment without professional medical advice. Genetic research is intended to improve our collective understanding of human biology, and while it offers valuable insights, it cannot replace the clinical judgment of a doctor.
How common is this variant?
The frequency of the rs147144681 variant is variable across different ancestral populations, with most current research data focused on individuals of European ancestry.
Frequently asked questions
Does having the rs147144681 variant mean I will become addicted to nicotine?
No, having this variant does not mean you will become addicted to nicotine. Nicotine dependence is a complex condition influenced by many genetic and environmental factors, and this variant is only one small piece of that puzzle.
Can I use this genetic information to help me quit smoking?
Genetic information is not a substitute for clinical advice. If you are trying to quit smoking, please speak with your doctor or a pharmacist, who can provide evidence-based cessation strategies tailored to your health needs.
Is this variant associated with other health conditions?
Research has explored links between the CHRNA5 gene cluster and various substance use disorders, as well as lung health. However, these associations are complex and are still being studied by the scientific community.
Why is the evidence for this variant considered limited?
Evidence is considered limited because, while the statistical association is strong, the biological mechanism is complex and influenced by many other factors. Additionally, more research is needed across diverse populations to fully understand the variant's impact.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs147144681?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CHRNA5
This variant serves as a lead SNP in cross-ancestry analyses of nicotine dependence.
This SNP is a well-known risk factor for nicotine dependence and lung cancer.
This variant is strongly associated with an increased risk of nicotine dependence and higher cigarette consumption per day.
This variant is strongly associated with nicotine dependence and smoking behavior in multiple large-scale studies.
Significantly increases the risk of nicotine dependence and lung cancer.